ReviewFrontiers in pharmacology2026
Alkaloids from Fritillariae Cirrhosae Bulbus - progress on their pharmacological activities.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fritillariae Cirrhosae Bulbus is a valuable and authentic medicinal material widely used in traditional Chinese medicine to treat respiratory diseases. Modern medical research shows that alkaloids, the main metabolites of Fritillariae Cirrhosae Bulbus, not only have expectorant and antitussive effects and can disperse swelling, but also have important clinical value and broad prospects for feed development in many areas, such as anti-tumor, antihypertensive, and antioxidant activities. This review systematically summarizes the types of alkaloids found in Fritillariae Cirrhosae Bulbus, including steroidal and isosteroidal forms, as well as six categories of pharmacological effects, such as antitussive, antiasthmatic, and antibacterial activities. It identifies current research challenges, namely, the unclear identification of active metabolites and the lack of elucidation of their mechanisms of action. This work offers a reference for further research and clinical application of Fritillariae Cirrhosae Bulbus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.